Last week Henry-Schein Announced 12% of the stock purchase by a Private Equity Firm.
KKR Acquires Major Stake in Henry Schein, Secures Board Seats
According to a recent report from the Wall Street Journal (cited by Reuters on January 29, 2025), global investment firm KKR & Co. has built a 12% stake in Henry Schein, a leading distributor of healthcare products and services. Alongside this purchase, KKR has also reached an agreement with Henry Schein to obtain representation on the company’s board of directors.
What’s Next?As Henry Schein adapts to shifting healthcare demands, KKR’s stake could unlock resources for new product lines, digital health innovations, or strategic partnerships. Analysts and stakeholders will be watching closely for any immediate changes in Henry Schein’s operational strategies or future acquisition plans.What does it mean for private practices?Dental supplies space is getting hot and both of the companies are feeling the pressure. We already addressed the pressures felt by Patterson Dental and now with this news it’s clear the changes are coming to the top dental distributors in the country. At the very least this adds pressure to stay competitive and will reflect on the prices for end users (lower cost of dental supplies). For additional details, visit the original Reuters coverage:
KKR builds stake in Henry Schein, reaches deal on board seats - WSJ (January 29, 2025)